Serina Therapeutics, Inc. Stockholders' Equity Attributable to Noncontrolling Interest
Serina Therapeutics, Inc. (SER) had Stockholders' Equity Attributable to Noncontrolling Interest of $0 as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2026-03-25
- 2025-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $0.00.
- 2025-09-30: Stockholders' Equity Attributable to Noncontrolling Interest -$166.00K.
- 2025-06-30: Stockholders' Equity Attributable to Noncontrolling Interest -$156.00K.
- 2025-03-31: Stockholders' Equity Attributable to Noncontrolling Interest -$142.00K.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest | Stockholders' Equity Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-25 | |
| 2025-09-30 | -$166.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$156.00K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | -$142.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$133.00K 10-K · filed 2026-03-25 | |
| 2024-09-30 | -$54.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$30.00K 10-Q · filed 2024-08-09 | |
| 2023-12-31 | $0.00 10-K · filed 2025-03-24 | -$111.00K 10-K · filed 2024-03-22 |
| 2023-09-30 | -$109.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$121.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$111.00K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | -$103.00K 10-K · filed 2024-03-22 | |
| 2022-09-30 | -$45.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$44.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | -$44.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | -$43.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$42.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | -$42.00K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | -$41.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | -$280.00K 10-K · filed 2022-03-29 | |
| 2020-09-30 | -$95.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $322.00K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $364.00K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $399.00K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $604.00K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $660.00K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $706.00K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $784.00K 10-K/A · filed 2020-03-31 | |
| 2017-12-31 | $1.04M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |